International Clinical Trial: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of Single and Multiple Ascending Doses of GV-100 (Part 1 & Part 2)

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ACTRN12626000762358) titled 'A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of Single and Multiple Ascending Doses of GV-100 (Part 1 & Part 2)' on June 26.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used)

Primary Sponsor: Gilva Therapeutics, INC.

Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Autosomal Dominant Polycystic Kidney Disease (ADPKD) Renal and Urogenital - Kidney disease

Intervention: This is a first-in-human, multi-part clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), food...